David R. Walt, PhD
Founder and Scientific Advisory Board Member
David Walt holds academic appointments at Tufts University as University Professor, Director of Tufts Institute for Innovation, Robinson Professor of Chemistry and Howard Hughes Medical Institute Professor Department of Chemistry. The Walt research lab focuses on bioanalytical chemistry, materials chemistry, biochemistry and nanoscience. The group is actively developing innovative array systems for monitoring enzyme mechanisms, DNA and protein detection, medical diagnostics, and cell populations.
As one of the founders of Illumina, Inc., a company that is the world leader in genomic analysis, David has been a director and Chairman of its Scientific Advisory Board since June 1998, the year of incorporation. The company provides a line of products and services that serve the sequencing, genotyping and gene expression markets, worldwide.
David is a Member of the National Academy of Engineering, a Fellow of the American Institute of Medical and Biological Engineers, and a Fellow of the American Association for the Advancement of Science. He has published over 300 papers, is named as an inventor or co- inventor of over 70 patents, and serves as a board member for Quanterix, Inc., a privately-held company focused on single molecule analysis for clinical diagnostics and Aurasense Therapeutics, an Illinois company using nanotechnology to deliver nucleic acid acids for multiple disease indications.
David holds a B.S. in Chemistry from the University of Michigan and received his Ph.D. in Chemical Biology from SUNY at Stony Brook. He is a part-time resident of Rockport, committed to establishing a world-class marine research institute in the region.